SIRT1 and coronary artery disorder: While in endothelial progenitor cells in CAD, atorvastatin and rosuvastatin elevated SIRT1 levels, demonstrating optimal efficacy at dosages of 0.5 as well as 10 μM (Tabuchi et al., 2012).